Related Experiment Video
Updated: Jan 23, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Pulmonary sequestration and endovascular treatment: a case report
Sergio Quilici Belczak1,2, Ingredy Tavares da Silva1, Jéssica Cunha Bernardes1
1Centro Universitário São Camilo, São Paulo, SP, Brasil.
Pulmonary sequestration, a lung anomaly, can cause recurrent pneumonia. Embolization of the abnormal blood vessel successfully treated a patient with this condition.
Area of Science:
- Pulmonology
- Vascular Surgery
- Congenital Anomalies
Background:
- Pulmonary sequestration is a congenital lung malformation characterized by non-functional lung tissue.
- It is classified as intralobar (75%) or extralobar (25%) based on the presence of a separate pleural envelope.
- Diagnosis typically involves imaging techniques like CT, MRI, or angiography.
Observation:
- A 29-year-old woman experienced recurrent pneumonia over five years.
- Chest CT revealed abnormal vascularization in the lower right lung, indicative of pulmonary sequestration.
- The patient had a history of recurrent pneumonia for 5 years.
Findings:
- The pulmonary sequestration was identified as the cause of the recurrent pneumonia.
- Endovascular treatment using embolization of the anomalous artery was performed.
- The anomalous branch feeding the sequestration was successfully embolized.
Implications:
- Endovascular embolization offers a minimally invasive alternative to traditional open surgery for pulmonary sequestration.
- This case highlights the effectiveness of embolization in managing symptomatic pulmonary sequestration.
- Successful embolization can resolve recurrent pulmonary infections associated with this congenital anomaly.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Data Reporting and Recording
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:

